Ceftazidime API market continues to demonstrate robust growth prospects, fueled by increasing demand for broad-spectrum antibiotics and advancements in pharmaceutical manufacturing. Ceftazidime API, a third-generation cephalosporin antibiotic, remains critically important in treating severe infections caused by pseudomonas aeruginosa and other gram-negative bacteria. While the market faces...
